Neurosigma Inc:企業の製品パイプライン分析

◆英語タイトル:Neurosigma Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME328927PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurosigma Inc (Neurosigma) is a life science company that develops and commercializes trigeminal nerve stimulation technologies for neurologic and psychiatric disorders. It offers Monarch eTNS System for treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD). The company offers treatments for epilepsy, depression, attention deficit hyperactivity disorder, and post-traumatic stress disorders. It also conducts preclinical research and development, and phase clinical trials. The company trigeminal nerve stimulation has been investigated as a therapy for epilepsy, depression, attention deficity hyperactivity disorder, and post-traumatic stress disorder, Lennox-Gastaut syndrome and traumatic brain injuries, among others. NeuroSigma is headquartered in Los Angeles, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Neurosigma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Neurosigma Inc Company Overview
Neurosigma Inc Company Snapshot
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc – Pipeline Analysis Overview
Neurosigma Inc – Key Facts
Neurosigma Inc – Major Products and Services
Neurosigma Inc Pipeline Products by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Pipeline Products Overview
Deep Brain Stimulation System – Cachexia
Deep Brain Stimulation System – Cachexia Product Overview
Deep Brain Stimulation System – Obesity
Deep Brain Stimulation System – Obesity Product Overview
DELTA Stent
DELTA Stent Product Overview
Micropatterned TFN Stent
Micropatterned TFN Stent Product Overview
Monarch eTNS System – ADHD
Monarch eTNS System – ADHD Product Overview
Monarch eTNS System – Depression
Monarch eTNS System – Depression Product Overview
Monarch eTNS System – Depression Clinical Trial
Monarch eTNS System – Epilepsy
Monarch eTNS System – Epilepsy Product Overview
Monarch eTNS System – Epilepsy Clinical Trial
Monarch eTNS System – Lennox-Gastaut Syndrome
Monarch eTNS System – Lennox-Gastaut Syndrome Product Overview
Monarch eTNS System – Post-Traumatic Stress Disorder
Monarch eTNS System – Post-Traumatic Stress Disorder Product Overview
Monarch eTNS System – Traumatic Brain Injury
Monarch eTNS System – Traumatic Brain Injury Product Overview
sTNS System – Epilepsy
sTNS System – Epilepsy Product Overview
Thin Film Nitinol Flow Diverting Stent
Thin Film Nitinol Flow Diverting Stent Product Overview
Neurosigma Inc – Key Competitors
Neurosigma Inc – Key Employees
Neurosigma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Neurosigma Inc, Recent Developments
Oct 08, 2019: NeuroSigma announces partnership with Quick Care Pharmacy for sales and distribution of the Monarch eTNS System in the US
Jun 27, 2019: NeuroSigma announces presentation of clinical trial data showing increased brain activity and improved cognition in children with ADHD Treated with eTNS
May 01, 2019: CCHR condemns FDA’s approval of Electricity-Zapping for ‘ADHD’ kids
Apr 23, 2019: NeuroSigma announces FDA clearance of Monarch eTNS System as first non-drug treatment for pediatric ADHD
Apr 23, 2019: FDA clears NeuroSigma’s Monarch device to treat ADHD
Oct 30, 2017: UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma’s Non-Invasive eTNS System for Treatment of Pediatric ADHD
Jan 28, 2016: Electric patch holds promise for treating PTSD
Dec 10, 2015: Preliminary Results Utilizing NeuroSigma’s Monarch eTNS System for the Treatment of Traumatic Brain Injury Presented at the North American Neuromodulation Society Annual Meeting
Nov 16, 2015: NeuroSigma’s Monarch eTNS System Receives CE Mark Approval for ADHD
May 04, 2015: NeuroSigma’s Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Neurosigma Inc Pipeline Products and Ongoing Clinical Trials Overview
Neurosigma Inc Pipeline Products by Equipment Type
Neurosigma Inc Pipeline Products by Indication
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc, Key Facts
Neurosigma Inc, Major Products and Services
Neurosigma Inc Number of Pipeline Products by Development Stage
Neurosigma Inc Pipeline Products Summary by Development Stage
Neurosigma Inc Ongoing Clinical Trials by Trial Status
Neurosigma Inc Ongoing Clinical Trials Summary
Deep Brain Stimulation System - Cachexia - Product Status
Deep Brain Stimulation System - Cachexia - Product Description
Deep Brain Stimulation System - Obesity - Product Status
Deep Brain Stimulation System - Obesity - Product Description
DELTA Stent - Product Status
DELTA Stent - Product Description
Micropatterned TFN Stent - Product Status
Micropatterned TFN Stent - Product Description
Monarch eTNS System - ADHD - Product Status
Monarch eTNS System - ADHD - Product Description
Monarch eTNS System - Depression - Product Status
Monarch eTNS System - Depression - Product Description
Monarch eTNS System - Depression - Effect of TNS for Major Depressive Disorder in the Elderly: A Phase II Randomized Controlled Trial
Monarch eTNS System - Depression - External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Depression
Monarch eTNS System - Depression - Transcutaneous Vagus Nerve Stimulation for Treating Major Depressive Disorder: A Phase II, Randomized, Double-blind Clinical Trial
Monarch eTNS System - Epilepsy - Product Status
Monarch eTNS System - Epilepsy - Product Description
Monarch eTNS System - Epilepsy - Evaluation of the Monarch eTNS Therapy for Neurological and Neuropsychiatric Disorders in Pediatrics
Monarch eTNS System - Epilepsy - External Trigeminal Nerve Stimulation for Epilepsy
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Status
Monarch eTNS System - Lennox-Gastaut Syndrome - Product Description
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Status
Monarch eTNS System - Post-Traumatic Stress Disorder - Product Description
Monarch eTNS System - Traumatic Brain Injury - Product Status
Monarch eTNS System - Traumatic Brain Injury - Product Description
sTNS System - Epilepsy - Product Status
sTNS System - Epilepsy - Product Description
Thin Film Nitinol Flow Diverting Stent - Product Status
Thin Film Nitinol Flow Diverting Stent - Product Description
Neurosigma Inc, Key Employees
Neurosigma Inc, Subsidiaries
Glossary

★海外企業調査レポート[Neurosigma Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thornton & Ross Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • Navidea Biopharmaceuticals Inc (NAVB)-製薬・医療分野:企業M&A・提携分析
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a precision medicine company that focuses on the development and commercialization of radiopharmaceutical agents and precision diagnostics. Its key product, Lymphoseek (technetium Tc 99m tilmanocept) injection, is a radiopharmaceutical agent used i …
  • BOOM Logistics Ltd (BOL):企業の財務・戦略的SWOT分析
    BOOM Logistics Ltd (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Apotex, Inc.:企業の戦略・SWOT・財務情報
    Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Berthold Technologies GmbH & Co. KG:企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Nagasaki University:製薬・医療:M&Aディール及び事業提携情報
    Summary Nagasaki University is an educational service provider that operates graduate schools, undergraduate schools, and research institutes. The university offers under graduate level education in the fields of economics, dentistry, pharmaceutical sciences, medicine, environmental studies, enginee …
  • Comvita Ltd (CVT):企業の財務・戦略的SWOT分析
    Comvita Ltd (CVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Axela Inc:医療機器:M&Aディール及び事業提携情報
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Burwill Holdings Limited:企業のM&A・事業提携・投資動向
    Burwill Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Burwill Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Endeavour Mining Corporation:企業のM&A・事業提携・投資動向
    Endeavour Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endeavour Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • GMR Infrastructure Limited (GMRINFRA)-エネルギー分野:企業M&A・提携分析
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Enterprises Private Limited, is a holding company which undertakes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv …
  • Greensmith Energy Management Systems LLC:電力:M&Aディール及び事業提携情報
    Summary Greensmith Energy Management Systems, LLC (Greensmith), a subsidiary of Wartsila Corporation, is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, …
  • QEP Resources, Inc. (QEP):石油・ガス:M&Aディール及び事業提携情報
    Summary QEP Resources Inc (QEP) is an independent oil and natural gas exploration and production company. It has operating interests in Northern Region chiefly in North Dakota, Wyoming and Utah; and Southern Region essentially in Texas and Louisiana. In Northern Region, the company owns productive w …
  • Siemens Medical Solutions USA Inc:企業のM&A・事業提携・投資動向
    Siemens Medical Solutions USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Medical Solutions USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Greene King PLC:企業の戦略・SWOT・財務情報
    Greene King PLC - Strategy, SWOT and Corporate Finance Report Summary Greene King PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Duravit AG:企業の戦略・SWOT・財務情報
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chart Industries Inc (GTLS):企業の財務・戦略的SWOT分析
    Chart Industries Inc (GTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Public Power Corporation SA (PPC):企業の財務・戦略的SWOT分析
    Public Power Corporation SA (PPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • OraSure Technologies Inc (OSUR):企業の財務・戦略的SWOT分析
    OraSure Technologies Inc (OSUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • OncoSec Medical Inc (ONCS):医療機器:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆